Top BEKhealth Alternatives

Transform your scattered health information into a cohesive and accessible format with an interactive AI and NLP platform that delivers critical health insights for a diverse range of stakeholders. This cutting-edge technology benefits Providers by expediting the data abstraction process and validating clinical information within notes, which in turn reduces the time and expenses linked to pinpointing care gaps, evaluating care quality through dashboards, and generating registry reports. For Payers, it enhances the integration and analysis of claims data alongside clinical notes, thereby improving the management of high-risk and high-cost member populations. In the Life Sciences sector, this solution accelerates patient matching for clinical trials by utilizing both databases and clinical note data, effectively tapping into the potential of real-world clinical evidence. Ember seamlessly combines NLP with predictive analytics, optimizing healthcare analytics for unstructured data to enhance quality, efficiency, and outcomes throughout the healthcare system. Consequently, stakeholders are empowered to make well-informed decisions that not only elevate patient care but also optimize resource allocation for better healthcare delivery. Ultimately, this holistic approach fosters a more connected and efficient healthcare ecosystem.

VIPER enhances the screening process by automating the identification of remote patients at the diagnosis phase, thereby ensuring that qualified candidates are enrolled. Utilizing artificial intelligence, the system adeptly aligns patients with precision trials during a vital enrollment window, drawing on lab-agnostic genomic data, electronic medical records (EMR), and pathology data that cater to individual patient profiles and specific research demands. The specialized matching engine rigorously searches for the most appropriate clinical trials that correlate with a patient's diagnosis as soon as it is made. Moreover, VIPER integrates seamlessly into existing workflows, providing real-time notifications about patient eligibility for ongoing trials, which keeps the entire healthcare team informed during this critical period. In addition to these features, VIPER incorporates interactive dashboards that facilitate extensive data mining, enabling the collection and analysis of site and study-level patient information to effectively achieve study key performance indicators (KPIs). This holistic strategy not only boosts the efficiency of trial recruitment but also significantly aids researchers in reaching their objectives with greater success. By continuously refining its processes, VIPER stands to further revolutionize the landscape of clinical trial enrollment.

No healthcare provider should have to sift through overwhelming and disorganized patient data. Our efficient and intuitive platform organizes even the most complex cases, guaranteeing that timely assessments and proactive care are readily available for everyone. It delivers a comprehensive, succinct, and context-sensitive clinical overview, enhancing the decision-making process. Navina flawlessly connects with your electronic health records, claims data, and a wide range of patient information, creating a cohesive experience. This actionable summary at the point of care not only improves treatment quality but also increases reimbursement rates. Essential information is often buried within the EHR system, leading to missed opportunities. By utilizing artificial intelligence, Navina brings that crucial data into focus, presenting it in a user-friendly format. Furthermore, we harness data analytics to highlight and recommend possible diagnoses while providing additional clinical insights from frequently neglected discharge documents, lab results, and other records. Our ultimate mission is to empower healthcare professionals with the necessary tools to deliver exceptional care while improving patient outcomes. This innovative approach ensures that no critical information is overlooked in the care continuum.

At Genospace, we understand that while progress in genomics is driving the advancement of precision medicine, the task of effectively scaling its implementation remains a significant hurdle. Our objective is to close this gap by leveraging our innovative platform, which is designed to convert biomedical data into actionable insights that are readily available to all, especially those involved in patient care. By empowering clinicians and researchers with crucial information, we enable them to make informed decisions while working toward our shared vision of using complex molecular data to improve patient outcomes and accelerate drug development and research processes. The importance of extensive population data for drug discovery and research is paramount in this endeavor. Take advantage of cohort-driven analyses through the Genospace platform to bolster your research projects. With a dedicated focus on clinical trial research, our platform effectively connects disparate patient data with intricate trial requirements, ensuring faster patient recruitment. Additionally, we aim to seamlessly weave genomic medicine into routine clinical practices, thus simplifying the integration of genomic insights into everyday healthcare. By collaborating closely, we can redefine the limits of patient care and research, ultimately fostering a more informed healthcare ecosystem.

Credo Health stands out as a cutting-edge SaaS platform powered by artificial intelligence, aimed at advancing the future of value-based healthcare. It provides essential support to physicians, MSOs, ACOs, and health plans by enabling them to accurately diagnose, document, and treat patients through a rich pool of clinical intelligence. By integrating diverse patient data, Credo’s platform creates comprehensive longitudinal records that fit seamlessly into current EHR workflows. Its AI-enhanced tools streamline the process of acquiring medical records, improve data analysis, increase patient engagement, and enhance overall performance. Clinicians benefit from receiving actionable insights directly during care delivery, which reduces the burden of administrative tasks. At the same time, administrators can utilize real-time analytics to improve the precision of risk adjustment and overall quality performance. Consequently, Credo Health empowers healthcare organizations to reduce costs, improve patient outcomes, and operate more effectively within value-based care models, heralding a significant transformation in the healthcare industry. This holistic strategy not only addresses immediate clinical demands but also promotes sustained advancements in healthcare service delivery, thereby benefiting both providers and patients alike.

Clinithink distinguishes itself as a leading technology company within the healthcare industry, specializing in artificial intelligence innovations that transform unstructured medical data into meaningful insights. Their proprietary platform, CLiX, utilizes Clinical Natural Language Processing (CNLP) to interpret complex clinical narratives, which in turn enables healthcare providers to enhance patient outcomes and boost operational efficiency. Clinithink offers tailored solutions across diverse sectors such as life sciences, revenue cycle management, and population health, effectively addressing challenges like patient cohort identification, reimbursement optimization, and disease progression tracking. With its state-of-the-art technology, Clinithink has garnered trust from major pharmaceutical and healthcare organizations worldwide, solidifying its position as a frontrunner in healthcare AI and digital health advancements. Additionally, the CLiX platform excels at recognizing a broad spectrum of complex clinical concepts, including certainty, severity, laterality, and temporality, which significantly improves its effectiveness in various clinical environments. As the healthcare landscape continues to evolve, Clinithink is dedicated to refining its technology to adapt to the shifting requirements of the industry, ensuring it remains at the forefront of innovation. This commitment to continuous improvement positions Clinithink as a critical partner in the quest for better healthcare solutions.

Our platform is meticulously crafted with a focus on regulatory compliance, enhancing the landscape of clinical research by employing advanced algorithms to analyze unstructured EMR data for the identification of critical health conditions. We are at the forefront of innovation, developing state-of-the-art technologies that expand access to transformative healthcare solutions through Clinical Trials. Our passionate team is driven by a mission to save lives by improving access to therapeutic advancements still under investigation. We firmly believe that every patient deserves to be informed and empowered about their options to participate in clinical trials that may provide substantial therapeutic advantages. As a progressive healthcare AI research organization, we have developed a sophisticated computational platform that accurately identifies patients who fulfill an extensive range of criteria necessary for participation in clinical trials, ensuring that those best suited are prioritized for these vital studies. Ultimately, our goal is to transform the way patients discover and engage with potentially life-altering treatment options, fostering a new era of healthcare possibilities. Through these efforts, we aspire to bridge the gap between innovative research and patient access, making a tangible difference in the healthcare landscape.

Altis Labs has introduced Nota, a groundbreaking platform aimed at improving the efficiency of therapeutic research and development in the clinical field. By leveraging artificial intelligence, Nota assesses imaging data to forecast patient outcomes, enabling sponsors to better concentrate on their most viable therapies. This cutting-edge tool equips researchers with the ability to utilize imaging data from clinical trials, access predictive biomarkers, and accelerate research initiatives on a broader scale. With Altis' cloud-based software that employs deep learning techniques, biopharma companies can achieve comprehensive outcome predictions at the levels of individual images, patients, and entire cohorts, thereby enhancing the design of clinical trials and boosting confidence in predicting clinical endpoints. The insights provided by Nota hold the potential to significantly shorten development timelines, reduce drug development costs, and increase the likelihood of success in clinical trials across diverse therapeutic areas. Furthermore, Nota signifies a major leap forward in the fusion of technology with clinical research, ultimately paving the way for more streamlined and effective drug development methodologies. This innovation not only promises to transform the landscape of clinical trials but also aims to improve patient outcomes in the long run.

MediLogix is an innovative clinical documentation platform that utilizes AI to greatly streamline and improve the creation of medical records for healthcare professionals. By processing a single patient encounter, clinicians can utilize the AI's capabilities to generate eight diverse types of detailed documents, such as complete transcripts, patient summaries, treatment strategies, and instructions for wound care or medications, along with coding recommendations, reusable templates, and analyses of protocols. In contrast to typical speech-to-text applications, this AI solution goes beyond mere transcription by continuously assessing clinical context in real-time to customize its outputs according to specific specialties, like cardiology or orthopedics, while preserving the individual physician's voice, reasoning, and decision-making processes instead of producing generic notes. Additionally, every output generated by the AI undergoes careful review by human medical transcriptionists, guaranteeing accuracy and the nuanced interpretation of elements such as tone, sentiment, and clinical subtleties that are essential for delivering high-quality patient care. This integration of advanced technology with human expertise not only enhances the documentation workflow but also allows healthcare providers to prioritize their interactions with patients more effectively, fostering better communication and overall care. Consequently, MediLogix represents a significant advancement in clinical documentation, bridging the gap between technology and personalized healthcare delivery.

Deep 6 AI transforms the patient enrollment landscape for clinical trials by innovatively altering the methods researchers use to locate appropriate candidates. Utilizing cutting-edge artificial intelligence and natural language processing, DEEP 6 AI adeptly navigates through both structured and unstructured patient data, allowing for the rapid identification of a broader range of well-suited trial participants in just minutes, a stark contrast to the months traditionally required. The platform works in conjunction with prominent health systems, pharmaceutical firms, and contract research organizations, establishing itself as a pivotal element of the clinical research framework and significantly accelerating patient access to trials. Beyond just speeding up enrollment, Deep 6 AI’s groundbreaking software analyzes structured data, such as ICD-10 codes, alongside unstructured clinical information like physician notes, pathology reports, and surgical documents, which can often be challenging to sift through. This thorough examination guarantees that researchers can swiftly locate candidates who fulfill specific requirements, thereby facilitating a quicker rollout of innovative treatments for those in need. Consequently, the integration of this technology not only enhances the efficiency of trial processes but also holds the potential to transform patient care by ensuring timely access to life-saving therapies.

Biorce's Aika is an innovative AI-powered clinical intelligence platform that revolutionizes the clinical trial lifecycle by converting labor-intensive processes for protocol creation and feasibility assessments into streamlined, evidence-based automation. Drawing on insights from nearly one million real-world trials, Aika can rapidly generate initial study protocols, detailed regulatory documents, site feasibility assessments, risk management plans, and other essential components of trials much quicker than traditional methods, thus reducing the likelihood of delays and costly revisions. This platform promotes complete transparency in its recommendation processes, empowering teams to confidently convey their decisions to regulatory bodies while ensuring expert supervision remains intact. Furthermore, Aika effectively marries the rapid efficiency of AI with deep clinical expertise, significantly shortening trial preparation durations from weeks to just days, which minimizes amendment risks and overall project vulnerabilities. By integrating seamlessly into current workflows without necessitating extensive retraining, Aika allows clinical trial teams to prioritize strategic decision-making over tedious administrative responsibilities. As a result, the focus shifts towards enhancing trial outcomes and optimizing resource allocation, ultimately driving innovation in clinical research practices.

We simplify clinical workflows, enabling healthcare professionals to focus on what is most important: their patients' well-being. Integrated with the electronic health record (EHR), Regard meticulously reviews the complete patient history, aiding in better diagnosis and treatment decisions. The benefits of using Regard have been proven to markedly improve hospital financial outcomes, enhance patient safety, and boost physician morale. By decreasing coding inquiries, lowering insurance claim rejections, and shortening chart review times, our goal is to revolutionize healthcare delivery. We encourage you to join our mission to ensure outstanding healthcare access for everyone. Tailored specifically for healthcare professionals, Regard streamlines workflow to create a more effective and enjoyable experience with the electronic medical record (EMR). Acting as an AI co-pilot that works effortlessly within the EMR, Regard serves as a virtual medical resident, structuring patient data, suggesting potential diagnoses, and automating the drafting of clinical notes. With Regard on your side, you'll find more time to engage in the medical aspects you love, while our technology expertly manages the complexities of data. Ultimately, Regard's AI co-pilot is an essential resource that not only elevates patient care but also enriches the experience for physicians, making it a transformative force in healthcare. As the landscape of medicine continues to evolve, having such innovative tools will be crucial in meeting the challenges ahead.

Limbic represents a groundbreaking clinical-AI platform tailored for professionals in behavioral health, enhancing patient access, expediting assessments, and providing effective therapy through trustworthy AI-powered tools. It smoothly integrates into existing referral systems and features Limbic Access, an interactive intake and screening tool that conducts evaluations, predicts diagnoses, gauges risk levels, and generates thorough clinical reports for healthcare providers. Additionally, Limbic offers Limbic Care, an AI-driven companion for patients that delivers structured cognitive-behavioral therapy (CBT) interventions, regular check-ins, and continuous support customized to the patient's therapeutic journey. At the core of this platform lies the Limbic Layer, a unique clinical engine that bridges users with a vast language model, ensuring safety, clinical precision, regulatory compliance, and consistency across the board. The platform's effectiveness is highlighted by its outstanding diagnostic accuracy and is backed by peer-reviewed studies and respected regulatory approvals, including its designation as a Class IIa medical device. Moreover, Limbic's dedication to advancing mental health care aligns with a larger movement in the healthcare sector towards the adoption of technology aimed at enhancing patient outcomes, illustrating its role in the future of psychological support. The integration of such innovative solutions marks a significant step forward in addressing the growing demand for accessible mental health resources.

Our cutting-edge technology, driven by artificial intelligence (AI), reshapes both structured and unstructured healthcare data into a reliable, high-quality, and standardized dataset suitable for application across your organization. By providing near real-time access to information from diverse systems, our solutions reduce the burden of manual data abstraction, allowing your administrative and clinical teams to regain precious time that can be redirected toward quality enhancements and research initiatives. Our comprehensive array of products and services equips you to collect, analyze, and leverage your data efficiently, regardless of its origin, therapeutic focus, departmental context, or existing reporting, business intelligence, or analytical frameworks. Atlas harnesses the combined strengths of human expertise and AI to simplify the complex task of discovering and interpreting patient data for clinical registries. In parallel, Cartographer adeptly navigates, assesses, and interprets patient information across various platforms, standardizing it into a cohesive format while delivering valuable insights. Ultimately, our groundbreaking solutions not only boost operational efficiency but also facilitate informed decision-making at every level of your organization, fostering a culture of continuous improvement and innovation. By integrating these advanced tools, you position your organization at the forefront of healthcare data management and strategic development.

Altris AI represents a groundbreaking clinical decision support system that utilizes artificial intelligence and operates in the cloud to assist eye care experts in interpreting OCT scans and enhancing their clinical decision-making processes. This innovative platform facilitates the swift identification of pathological OCT scans while demonstrating the capability to recognize more than 70 different retinal pathologies and biomarkers, including some that are relatively rare. Key features include assessing the severity of conditions, analyzing retinal layer thickness, segmenting various layers, detecting pathologies, and executing both automatic and manual measurements. Altris AI is designed to work seamlessly with all OCT devices and supports multiple formats like DICOM, JPEG, and PNG. The system has received FDA clearance and CE certification and complies with GDPR and HIPAA regulations, thus ensuring the highest standards of data security and patient confidentiality. By integrating Altris AI into their clinical workflows, eye care professionals can significantly enhance patient triage, boost diagnostic accuracy, and monitor disease progression more effectively, which contributes to improved patient outcomes. Furthermore, this state-of-the-art technology not only empowers eye care providers to make better-informed decisions but also promotes an overall atmosphere of enhanced patient care and innovative treatment approaches. Ultimately, the adoption of Altris AI can transform the landscape of eye care, leading to advancements in both patient management and clinical practices.

Improving the speed, accuracy, and cost-effectiveness of cancer diagnoses is essential, given that one in three people are likely to confront this illness in their lives. The existing diagnostic methods, however, are often slow and expensive, primarily due to a shortage of sophisticated automated tools that can aid healthcare providers. Qritive seeks to overcome this issue by providing an AI-powered solution that assists doctors in efficiently analyzing microscopy images alongside patient data. This breakthrough not only improves the diagnostic capabilities of hospitals but also results in substantial savings in healthcare costs. Furthermore, Pantheon acts as a CE-marked, vendor-neutral digital pathology platform that streamlines the entire digitization process for pathology laboratory workflows and telepathology services. It also enables thorough report generation and offers a powerful environment for AI-based analysis of whole-slide images in pathology. This innovative technology excels at differentiating between various benign conditions and malignant diseases in breast tissue, which is crucial for ensuring timely and precise treatment. By doing so, it significantly contributes to the evolution of cancer diagnostics and enhances patient outcomes in the long run.

Improving the quality of care and outcomes for cancer patients requires an integrated approach that involves healthcare providers, researchers, cancer organizations, and the patients themselves. Oncora's user-friendly software platform equips all stakeholders with the ability to collect and analyze real-world data, enabling healthcare decisions that focus on the well-being of patients. Our solutions cater specifically to healthcare professionals dedicated to enhancing cancer treatment outcomes. By streamlining workflows, easing documentation burdens, and refining care with intelligent software solutions, we strive to create a more effective healthcare experience. Our user-friendly tools facilitate the capture and visualization of regulatory-grade real-world data, which is crucial for making informed decisions. With advanced reporting features, you can assess quality and improve operations to enhance patient care significantly. Partnering in comprehensive clinical research with top cancer care specialists further solidifies our dedication to improving the field. The web-based software we provide is customized to satisfy the unique requirements of your cancer center, offering data and resources that accelerate clinical advancements and innovations. Ultimately, our goal is to revolutionize cancer care through the synergy of technology and collaboration, ensuring patients benefit from the best possible care available. By fostering these connections, we can drive meaningful change in the fight against cancer.

Citeline acts as a comprehensive platform for intelligence and analytics in clinical development, providing life sciences companies with essential real-time data, insights, and tools necessary for making well-informed strategic decisions throughout the drug and device development journey. By gathering and refining an extensive array of datasets concerning global clinical trials, investigators, trial sites, drug development pipelines, and regulatory requirements, it supports multiple functions, including protocol design, feasibility studies, site and investigator selection, enrollment forecasting, competitive analysis, and adherence to disclosure regulations across various regions. The platform features a variety of products, such as Pharmaprojects for tracking drug pipelines, Trialtrove for benchmarking clinical trials, Sitetrove for acquiring site and investigator information, Global Patient Insights to ensure feasibility matches actual patient access, and TrialScope Intelligence/Disclose to navigate the intricacies of regulatory disclosure mandates. Citeline’s diverse functionalities make it an indispensable asset for organizations seeking to optimize their clinical development workflows and improve their strategic decision-making processes. Furthermore, the seamless integration of these tools not only enhances efficiency but also equips organizations to adeptly handle the challenges associated with clinical trials and regulatory compliance in a constantly changing environment. This adaptability is crucial for maintaining competitiveness and ensuring successful outcomes in the fast-paced life sciences sector.

Pearl has developed a groundbreaking platform that utilizes artificial intelligence to assist healthcare teams in reducing unnecessary costs, improving patient outcomes, and succeeding in value-based care by identifying key patients and promoting timely interventions, all while integrating smoothly into current workflows to avoid any disruptions. This advanced technology combines predictive analytics with actionable strategies, focusing on substantial outreach and automating follow-up processes, assessing provider preparedness and cohort risk to match participants with appropriate payment models, and translating intelligence into meaningful actions that drive improvements in clinical, financial, and operational performance. Furthermore, the platform is designed to integrate effortlessly into existing provider systems, allowing healthcare teams to deliver exceptional care on a broader scale. With its sophisticated data science and actuarial features, it maximizes cost savings, enhances performance benchmarks, and accommodates various models such as ACO REACH, MSSP, and Medicare Advantage, while providing physicians with intuitive tools that simplify care delivery, reduce their burden of routine tasks, and improve the management of patient panels. Ultimately, Pearl's solution distinguishes itself in the healthcare sector by emphasizing both efficiency and effectiveness in care delivery, ensuring that its comprehensive features yield significant benefits for both providers and patients alike, and paving the way for a more sustainable healthcare future.

Amazon Comprehend Medical is an NLP service designed to adhere to HIPAA standards, employing machine learning to extract health information from medical documents without necessitating any prior expertise in machine learning from its users. A vast amount of healthcare data is found in unstructured formats, such as physicians' notes, clinical trial reports, and patient histories. Relying on traditional, manual methods for data extraction is not only time-consuming but also prone to errors, as rule-based automation often fails to capture essential contextual details, resulting in incomplete data retrieval. This lack of reliability can significantly undermine the effectiveness of large-scale analytics, which are critical for advancements in the healthcare and life sciences industries, ultimately impeding potential enhancements in patient care and operational effectiveness. By utilizing this sophisticated service, healthcare organizations can gain invaluable insights and improve their decision-making capabilities, ultimately leading to better outcomes for patients. This transformative approach represents a significant leap forward in how health data can be leveraged for greater efficiency and efficacy in medical practices.

Predoc has introduced a cutting-edge health information management platform that utilizes artificial intelligence to streamline the retrieval, organization, and analysis of patient records. This advanced system empowers healthcare organizations to access records from any provider across the United States, regardless of whether the sources are digital or manual, and it can deliver fully integrated records in just minutes or days, thus mitigating the delays inherent in traditional methods. By aggregating and indexing clinical data from various formats, including PDFs, the platform effectively reorganizes previously chaotic patient information into a structured format that adheres to HIPAA regulations. Furthermore, its AI is specifically trained in clinical contexts and diligently reviews extensive patient files, pinpointing the most relevant clinical details crucial for effective patient care and research initiatives. Users have experienced significant advancements in efficiency, reporting retrieval times that are up to 80% faster, a 70% decrease in time dedicated to chart reviews, and an overall cost reduction of about 50% compared to older solutions. The groundbreaking abilities of Predoc not only accelerate operational processes but also greatly enhance the quality of care delivered to patients. As a result, healthcare providers can focus more on patient interaction and less on administrative tasks, ultimately fostering a more effective healthcare environment.

ConcertAI emerges as a leading provider of AI-powered solutions in the healthcare industry, with a significant emphasis on oncology. The company's primary goal is to improve patient outcomes and accelerate insights by utilizing high-quality real-world data, innovative AI technologies, and profound scientific expertise. They offer a comprehensive range of products and services designed to enhance both clinical research and the experiences of patients. Their Real-World Data Products provide extensive and tailored datasets that meet a variety of research requirements for different organizations. By streamlining clinical trial processes, their digital trial solution boosts efficiency, while the Clinical Trial Optimization (CTO) platform harnesses advanced AI capabilities to enhance the design and execution of trials, particularly in oncology and hematology. Furthermore, in collaboration with NeoGenomics, ConcertAI has launched CTO-H, a software-as-a-service (SaaS) offering that focuses on hematological malignancies, delivering advanced research analytics and improving operational workflows. This combination of innovative technologies not only bolsters research capabilities but also plays a crucial role in advancing patient care within challenging medical specialties. Ultimately, ConcertAI's commitment to integrating AI into healthcare is reshaping the landscape of oncology and enhancing overall treatment pathways.

Microsoft Cloud for Healthcare is a comprehensive platform designed to transform the healthcare landscape through the implementation of AI-driven solutions, data integration, and the promotion of secure, interconnected experiences. It supports healthcare providers, payors, and life sciences organizations in improving patient care, refining operations, and enhancing research initiatives. The platform offers tools that safeguard sensitive information, streamline clinical workflows, and promote increased patient engagement. By leveraging actionable insights from combined clinical and operational data, Microsoft Cloud for Healthcare enables healthcare organizations to realize better outcomes, increase efficiency, and reduce costs. Furthermore, this cutting-edge platform plays a crucial role in shaping the trajectory of healthcare delivery, driving innovation, and facilitating a more responsive healthcare ecosystem. In doing so, it paves the way for a future where healthcare is not only more effective but also more accessible to all.

Feather is an advanced medical AI chat platform designed specifically for healthcare professionals, ensuring adherence to HIPAA regulations while securely managing sensitive patient data and improving operational efficiency. It features a range of services including AI-enhanced clinical transcription, DICOM image analysis applicable to multiple medical imaging types, and the automatic generation of SOAP and BIRP clinical notes, all backed by secure cloud storage for confidential medical records. Key Highlights - A user-friendly AI chat interface that enables smooth interaction with patient records, lab results, and clinical documentation within a cohesive workspace. - Guarantee of HIPAA compliance through the secure management of protected health information (PHI), utilizing encrypted cloud storage solutions for medical data. - Streamlining of clinical documentation processes with AI, producing SOAP and BIRP notes from real-time interactions to alleviate administrative workloads. - Sophisticated AI capabilities for the analysis of medical images, including MRI, CT scans, X-rays, and ultrasounds, which enhances diagnostic accuracy. - Support for the summarization and critical evaluation of diverse medical reports, such as laboratory, radiology, and pathology findings, to facilitate informed decision-making. - Additionally, the platform is committed to improving the overall efficiency and safety of healthcare delivery by integrating innovative technology into everyday practices, thereby revolutionizing patient care.

OnPoint Healthcare Partners offers an advanced, AI-enabled autonomous practice management platform along with a suite of healthcare technology solutions aimed at improving clinical documentation, coding precision, care coordination, revenue cycle management, and administrative tasks, thus enabling healthcare providers and their teams to focus more fully on patient care. At the heart of this innovative solution is the Iris Medical Agent AI Platform, a cloud-based tool that utilizes agentic and generative AI under clinical oversight to carry out tasks across the entire care continuum, featuring capabilities such as AI-enhanced charting, accurate coding compliance, longitudinal patient management for HCC risk adjustment, initiatives for closing care gaps, and immediate support for care coordination and referral/prior authorization, all integrated smoothly with existing EHR systems to reduce interruptions and lessen manual effort. Furthermore, OnPoint’s Practice Management as a Service model combines these autonomous AI workflows with operational expertise to address staffing shortages, lower costs, and streamline healthcare operations. This all-encompassing strategy not only boosts operational efficiency but also empowers providers to offer superior care to their patients while maintaining focus on their well-being. In essence, OnPoint is transforming the landscape of healthcare management with innovative solutions that prioritize patient care above all else.

Revolutionize your healthcare experience with the groundbreaking Soliton® AI, which harnesses the power of 30,000 evidence-based rules alongside cutting-edge machine learning technologies. By streamlining a range of healthcare and management functions, Soliton® provides you with essential tools to excel in a value-driven care setting, showcasing unparalleled capabilities. It processes extensive patient data in real-time, which leads to improvements in both clinical outcomes and financial results while also accommodating various Alternative Payment Models (APMs). The platform enhances telehealth services by anticipating billable codes during patient consultations and estimating future healthcare expenses through advanced risk stratification techniques. Additionally, it offers timely clinical decision support that aids in the management of complex patient populations. Soliton® also enhances the patient journey by ensuring smooth transitions from acute to post-acute care through AI-enhanced care coordination. It effectively identifies gaps in care, reveals service and coding opportunities, and develops customized patient assessments and individualized care plans, all while allowing for the formation of specific cohorts for focused interventions. Consequently, Soliton® not only boosts operational efficiency but also significantly improves the overall quality of care provided to patients, ultimately leading to better health outcomes and satisfaction. Such innovations position Soliton® as a critical asset in modern healthcare delivery.

EVIDENS is a cutting-edge AI platform designed to streamline the identification of digital cohorts, enhancing research capabilities and fostering collaboration while allowing insights to be shared across vast hospital data sets. Users can quickly annotate and transform data into formats compatible with AI, enabling them to filter populations based on diverse clinical outcomes or demographic characteristics efficiently. The platform supports extensive keyword filtering, empowering users to train AI models for precise searches. In addition, intelligent AI tools assist users in exploring and setting criteria for identifying cohorts. The automation of the analysis process through AI model training allows for the rapid categorization of data into well-defined groups. EVIDENS produces AI-ready cohorts that facilitate the testing of clinical hypotheses in various research studies. Users can easily track the progress and tasks of all their projects and collaborators, as well as engage with activities related to their specific research interests. Furthermore, the platform includes collaborative tools that encourage simultaneous efforts in the creation, training, and validation of AI models, thereby nurturing a thriving research environment. Overall, EVIDENS not only simplifies the research process but also enhances the effectiveness and efficiency of all participants involved, making it a pivotal tool in contemporary research settings. By leveraging such advanced capabilities, researchers can unlock new possibilities in understanding complex medical data.

Techcyte is at the forefront of developing cutting-edge machine learning applications tailored for cellular and liquid environments, aimed at bolstering the capabilities of laboratories and professionals engaged in digital diagnostics. Our dedication lies in delivering all-encompassing solutions that ensure a seamless and efficient user experience throughout every phase, from sample preparation to workflow execution and image analysis, thereby guaranteeing consistent and reliable results. We understand that the most impactful advancements in technology and healthcare arise from the creativity and commitment of skilled individuals. Our Cervical Cytology System exemplifies this innovation, serving as a revolutionary screening tool that empowers cytotechnologists and pathologists to assess Hologic ThinPrep® or BD SurePath™ slides more effectively by significantly reducing the cell count they must evaluate while emphasizing the most diagnostically relevant cells and organisms through our sophisticated AI-driven algorithms. This not only refines the diagnostic process but also significantly enhances the overall quality of patient care. Furthermore, our ongoing commitment to integrating advanced technology into laboratory workflows ensures that healthcare professionals are better equipped to provide timely and accurate diagnoses, ultimately leading to improved health outcomes for patients.

Latent Health represents a groundbreaking platform for medication access that utilizes artificial intelligence to improve and speed up the administrative processes that often obstruct patients from obtaining essential specialty and lifesaving treatments, especially concerning prior authorizations, appeals, and 340B eligibility. Through its sophisticated clinical-AI capabilities, the platform evaluates and deciphers electronic health records in conjunction with external data sources, such as clinical guidelines and research papers, to extract relevant patient details, address specific authorization queries, evaluate medical benefit criteria, and even compose appeal letters. This innovation dramatically reduces review and turnaround times from hours or days to just minutes, all while enhancing accuracy and compliance in the process. Furthermore, Latent Health integrates smoothly with prominent electronic health record (EHR) systems, following healthcare standards like SMART on FHIR, and supports centralized pharmacy functions as well. The platform also features workflow orchestration tools that mitigate administrative burdens, improve operational efficiency, and allow clinical personnel to focus more on direct patient care, which ultimately contributes to better health outcomes and greater patient satisfaction. By simplifying these vital processes, Latent Health is set to revolutionize how healthcare providers approach medication access, making it more efficient and patient-centered than ever before. This transformation has the potential to significantly elevate the overall quality of care delivered to patients.

OM1 harnesses the power of artificial intelligence alongside comprehensive clinical datasets to greatly improve both research efficiency and clinical decision-making through advanced predictive modeling. The OM1 Patient Finder utilizes cutting-edge AI technology that is seamlessly integrated with the OM1 Real-World Data Cloud. By synthesizing various elements of patient journeys from a wide range of data sources, it adeptly pinpoints individuals who are most susceptible to the target condition. We have engineered a sophisticated data cloud that empowers diverse healthcare stakeholders to access, scrutinize, and apply outcomes data in a manner that is not only more thorough but also clinically relevant and accurate. This innovation facilitates quick, precise, and cost-effective access to research-grade insights regarding efficacy, value, and safety. Additionally, it supports the quantification of outcomes, which is essential for showcasing value in risk-sharing and outcomes-based payment frameworks. Consequently, healthcare providers are enabled to make well-informed decisions based on real-world evidence, ultimately improving patient care and health system effectiveness. This integration of AI and real-world data is poised to transform the landscape of healthcare analytics and decision-making.